摘要
目的评价化瘀通络汤联合低分子肝素钙对进展性脑梗死患者神经功能及不良反应的影响。方法选取门诊于2017年7月—2018年8月收治的100例进展性脑梗死患者,按照随机数字表法分为对照组和观察组,2组各50例患者。对照组患者采用低分子肝素钙治疗,观察组在此基础上给予中医汤药化瘀通络汤联合治疗,观察并对比2组患者神经功能的恢复情况以及治疗期间不良反应的总发生率。结果对照组总有效率低于观察组,差异有统计学意义(P<0.05);观察组神经功能损伤评分(9.66±3.44)低于对照组(15.49±4.15),差异有统计学意义(P<0.05);观察组NIHSS评分治疗后低于对照组,差异有统计学意义(P<0.05);不良反应总发生率低于对照组,差异有统计学意义(P<0.05)。结论化瘀通络汤联合低分子肝素钙治疗进展性脑梗死,可帮助患者大大降低治疗不良反应的总发生率,提高机体康复效率以及帮助神经功能的恢复。
Objective To evaluate the effect of Huayu Tongluo decoction combined with low molecular weight heparin calcium on the neurological function and adverse reaction of the patients with progressive cerebral infarction.Methods 100 patients with progressive cerebral infarction from July 2017 to August 2018 were selected and divided into control group and observation group according to the random number table method.In the control group,the low molecular weight heparin calcium treatment was used,and the observation group was also given Huayu Tongluo decoction.The recovery of the neurological function in the two groups and the overall incidence of the adverse reactions during the treatment period were observed.Results The total effective rate of the control group was lower than that of the observation group(P<0.05).The functional damage of the observation group(9.66±3.44)was lower than that in the control group(15.49±4.15)(P<0.05),and the total incidence of vomiting,nausea and headache in the observation group was significantly lower than that in the control group(P<0.05).Conclusion Huayu Tongluo decoction combined with low molecular weight heparin calcium in the treatment of progressive cerebral infarction can greatly reduce the total incidence of adverse reactions,improve the rehabilitation efficiency and help the recovery of neurological function.
作者
马峥尧
MA Zhengyao(Department of Internal Medicine,Tiedong District Hospital,Liaoning Province,Anshan 114000,China)
出处
《光明中医》
2020年第7期1050-1053,共4页
GUANGMING JOURNAL OF CHINESE MEDICINE
关键词
化瘀通络汤
低分子肝素钙
进展性脑梗死
神经功能
不良反应
Huayu Tongluo decoction
low molecular weight heparin calcium
progressive cerebral infarction
neurological function
adverse reactions
